Search - tctmd.com

Displaying 561 - 580 of 3682

Sort: Relevancy | Date

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

August 28, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Presentation ESC 2016

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Presenter: Gilles Montalescot

August 28, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

August 28, 2016

News Conference News ESC 2016

Thrombectomy for Stroke in a Cardiology Department: Preliminary Study Explores the Possibilities

August 27, 2016

News Conference News ESC 2016

New ESC A-fib Guidelines Call for Integrated Care for All Patients

August 27, 2016

News Conference News ESC 2016

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

August 27, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

ESC-EAS Guidelines for the Management of Dyslipidaemias

Presentation ESC 2016

ESC-EAS Guidelines for the Management of Dyslipidaemias

Presenter: Ian Graham

August 27, 2016

Cancer Treatments And Cardiovascular Toxicity Developed Under The Auspices Of The ESC Committee for Practice Guidelines

Presentation ESC 2016

Cancer Treatments And Cardiovascular Toxicity Developed Under The Auspices Of The ESC Committee for Practice Guidelines

Presenter: Patrizio Lancellotti

August 27, 2016

News Daily News

Conflicts of Interest Widespread Among Canadian Guideline Writers

August 26, 2016

News Daily News

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

August 25, 2016

News Daily News

Depression Increases Risk of Acute MI by 30% in HIV-Positive Patients

August 25, 2016

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Daily News

‘Shotgunning’ Approach Appears to Knock Down Readmissions After PCI

August 25, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

August 24, 2016

News Daily News

Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo

August 24, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.